Search Results - "Porras de Francisco, Esther"
-
1
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis
Published in Proceedings of the National Academy of Sciences - PNAS (02-08-2016)“…The rising incidence of antimicrobial resistance (AMR) makes it imperative to understand the underlying mechanisms. Mycobacterium tuberculosis (Mtb) is the…”
Get full text
Journal Article -
2
Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence
Published in Science advances (01-03-2019)“…The stringent response enables ( ) to shut down its replication and metabolism under various stresses. Here we show that lacking the stringent response enzyme…”
Get full text
Journal Article -
3
Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis
Published in Journal of medicinal chemistry (27-12-2018)“…Society urgently needs new, effective medicines for the treatment of tuberculosis. To kick-start the required hit-to-lead campaigns, the libraries of…”
Get full text
Journal Article -
4
Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis
Published in ACS infectious diseases (09-08-2019)“…The historical view of β-lactams as ineffective antimycobacterials has given way to growing interest in the activity of this class against Mycobacterium…”
Get full text
Journal Article -
5
Microwave‐Assisted Suzuki‐Miyaura Cross Coupling using Nickel as Catalyst to Rapidly Access to 3‐Arylazetidine
Published in ChemistrySelect (Weinheim) (29-09-2017)“…The efficient synthesis of 3‐arylazetidine derivatives is reported using a Nickel‐catalyzed Suzuki‐Miyaura coupling between arylboronic acids and a…”
Get full text
Journal Article -
6
MymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against Mycobacterium tuberculosis
Published in Journal of medicinal chemistry (14-05-2020)“…Screening of a GSK-proprietary library against intracellular Mycobacterium tuberculosis identified 1, a thioalkylbenzoxazole hit. Biological profiling and…”
Get full text
Journal Article -
7
Identification of β‑Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions
Published in ACS infectious diseases (11-03-2022)“…Rising antimicrobial resistance challenges our ability to combat bacterial infections. The problem is acute for tuberculosis (TB), the leading cause of death…”
Get full text
Journal Article -
8
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis
Published in ACS infectious diseases (11-12-2015)“…Identification of compounds that target metabolically diverse subpopulations of Mycobacterium tuberculosis (Mtb) may contribute to shortening the course of…”
Get full text
Journal Article -
9
Correction to “Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis”
Published in ACS infectious diseases (13-12-2019)Get full text
Journal Article